← FDA Drug Approvals (Drugs@FDA)
SILODOSIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-12-08
Drug application
- FDA Application #
ANDA204816- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SILODOSIN
- Generic name
- Silodosin
- Active ingredients
- SILODOSIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ZYDUS PHARMS
- First approval
- 2022-12-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown